213 related articles for article (PubMed ID: 20712882)
1. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
[TBL] [Abstract][Full Text] [Related]
2. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
3. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T
Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754
[TBL] [Abstract][Full Text] [Related]
4. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
5. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
7. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C
Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617
[TBL] [Abstract][Full Text] [Related]
9. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
Zabetian S; Mehregan D
Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
11. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract][Full Text] [Related]
12. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
13. PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.
Gonzalez-Angulo AM; Ferrer-Lozano J; Stemke-Hale K; Sahin A; Liu S; Barrera JA; Burgues O; Lluch AM; Chen H; Hortobagyi GN; Mills GB; Meric-Bernstam F
Mol Cancer Ther; 2011 Jun; 10(6):1093-101. PubMed ID: 21490305
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
15. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations.
Sabaté JM; Gómez A; Torrubia S; Blancas C; Sánchez G; Alonso MC; Lerma E
Eur Radiol; 2006 Mar; 16(3):702-6. PubMed ID: 16208511
[TBL] [Abstract][Full Text] [Related]
17. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
18. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of TAS-117 in patients with advanced solid tumors harboring germline
Rodón J; Funchain P; Laetsch TW; Arkenau HT; Hervieu A; Singer CF; Murciano-Goroff YR; Chawla SP; Anthony K; Yamamiya I; Liu M; Halim AB; Benhadji KA; Takahashi O; Delaloge S
Future Oncol; 2022 Sep; 18(30):3377-3387. PubMed ID: 36039910
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.
Singh G; Odriozola L; Guan H; Kennedy CR; Chan AM
BMC Cancer; 2011 Nov; 11():490. PubMed ID: 22103913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
